

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.16577573 |
| 2 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 6.09525970 |
| 3 | locomotory exploration behavior (GO:0035641) | 6.05060664 |
| 4 | vocalization behavior (GO:0071625) | 5.91050088 |
| 5 | synaptic vesicle maturation (GO:0016188) | 5.83351727 |
| 6 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.72545637 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 5.49128915 |
| 8 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.35881807 |
| 9 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.32181559 |
| 10 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.31622082 |
| 11 | sodium ion export (GO:0071436) | 5.24630189 |
| 12 | glutamate secretion (GO:0014047) | 5.24106385 |
| 13 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.19340708 |
| 14 | protein localization to synapse (GO:0035418) | 5.07181681 |
| 15 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.02247529 |
| 16 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.98832091 |
| 17 | muscle filament sliding (GO:0030049) | 4.86622868 |
| 18 | actin-myosin filament sliding (GO:0033275) | 4.86622868 |
| 19 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.81341025 |
| 20 | regulation of synapse structural plasticity (GO:0051823) | 4.72178404 |
| 21 | exploration behavior (GO:0035640) | 4.68610418 |
| 22 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.67342251 |
| 23 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.64710659 |
| 24 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.64401209 |
| 25 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.63013769 |
| 26 | neuron cell-cell adhesion (GO:0007158) | 4.61018392 |
| 27 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.52575019 |
| 28 | neuronal action potential propagation (GO:0019227) | 4.48834302 |
| 29 | regulation of synaptic vesicle transport (GO:1902803) | 4.44286757 |
| 30 | neurotransmitter secretion (GO:0007269) | 4.37323621 |
| 31 | synaptic transmission, glutamatergic (GO:0035249) | 4.29613116 |
| 32 | dendritic spine morphogenesis (GO:0060997) | 4.23497574 |
| 33 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.19247072 |
| 34 | neuron-neuron synaptic transmission (GO:0007270) | 4.17432096 |
| 35 | glutamate receptor signaling pathway (GO:0007215) | 4.14447367 |
| 36 | regulation of cell communication by electrical coupling (GO:0010649) | 4.13261928 |
| 37 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.12329212 |
| 38 | regulation of relaxation of muscle (GO:1901077) | 4.12186139 |
| 39 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.11584173 |
| 40 | layer formation in cerebral cortex (GO:0021819) | 4.09084892 |
| 41 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.06823415 |
| 42 | positive regulation of membrane potential (GO:0045838) | 4.06526991 |
| 43 | long-term memory (GO:0007616) | 4.02505106 |
| 44 | L-amino acid import (GO:0043092) | 4.02414491 |
| 45 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.94927705 |
| 46 | proline transport (GO:0015824) | 3.94560738 |
| 47 | actin-mediated cell contraction (GO:0070252) | 3.92162115 |
| 48 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.91339045 |
| 49 | regulation of skeletal muscle contraction (GO:0014819) | 3.87153736 |
| 50 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.86062704 |
| 51 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.85775040 |
| 52 | regulation of postsynaptic membrane potential (GO:0060078) | 3.84346120 |
| 53 | striated muscle contraction (GO:0006941) | 3.80319004 |
| 54 | regulation of synaptic plasticity (GO:0048167) | 3.79758861 |
| 55 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.78912998 |
| 56 | positive regulation of synapse maturation (GO:0090129) | 3.78630803 |
| 57 | cerebellar granule cell differentiation (GO:0021707) | 3.78101151 |
| 58 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.75309900 |
| 59 | auditory behavior (GO:0031223) | 3.73161187 |
| 60 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.71183001 |
| 61 | potassium ion import (GO:0010107) | 3.69375062 |
| 62 | long-term synaptic potentiation (GO:0060291) | 3.65401818 |
| 63 | skeletal muscle contraction (GO:0003009) | 3.64400209 |
| 64 | cell communication by electrical coupling (GO:0010644) | 3.63925195 |
| 65 | gamma-aminobutyric acid transport (GO:0015812) | 3.61453124 |
| 66 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.59729725 |
| 67 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.59729725 |
| 68 | regulation of neurotransmitter secretion (GO:0046928) | 3.57887875 |
| 69 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.57418437 |
| 70 | response to auditory stimulus (GO:0010996) | 3.55864731 |
| 71 | transmission of nerve impulse (GO:0019226) | 3.55845342 |
| 72 | cardiac muscle contraction (GO:0060048) | 3.55740315 |
| 73 | positive regulation of neurotransmitter transport (GO:0051590) | 3.55638211 |
| 74 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.54858925 |
| 75 | postsynaptic membrane organization (GO:0001941) | 3.54137891 |
| 76 | amino acid import (GO:0043090) | 3.52160050 |
| 77 | myofibril assembly (GO:0030239) | 3.50247101 |
| 78 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.49509134 |
| 79 | activation of protein kinase A activity (GO:0034199) | 3.47389832 |
| 80 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.46679257 |
| 81 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.45998437 |
| 82 | neurotransmitter transport (GO:0006836) | 3.44998388 |
| 83 | potassium ion homeostasis (GO:0055075) | 3.44104629 |
| 84 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.43302373 |
| 85 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.40786899 |
| 86 | prepulse inhibition (GO:0060134) | 3.40518168 |
| 87 | regulation of dendritic spine development (GO:0060998) | 3.38636333 |
| 88 | neuromuscular process controlling balance (GO:0050885) | 3.36673248 |
| 89 | neuron recognition (GO:0008038) | 3.35691351 |
| 90 | presynaptic membrane assembly (GO:0097105) | 3.34030648 |
| 91 | regulation of neurotransmitter transport (GO:0051588) | 3.32114844 |
| 92 | neuromuscular synaptic transmission (GO:0007274) | 3.29961355 |
| 93 | synaptic vesicle endocytosis (GO:0048488) | 3.29866749 |
| 94 | cellular potassium ion homeostasis (GO:0030007) | 3.28887825 |
| 95 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.28412495 |
| 96 | learning (GO:0007612) | 3.28270311 |
| 97 | regulation of synapse maturation (GO:0090128) | 3.26052328 |
| 98 | regulation of actin filament-based movement (GO:1903115) | 3.25962942 |
| 99 | membrane depolarization (GO:0051899) | 3.24198028 |
| 100 | response to histamine (GO:0034776) | 3.21696508 |
| 101 | response to parathyroid hormone (GO:0071107) | 3.19999600 |
| 102 | regulation of vesicle fusion (GO:0031338) | 3.19864915 |
| 103 | negative regulation of dendrite development (GO:2000171) | 3.19566910 |
| 104 | glycine transport (GO:0015816) | 3.18095690 |
| 105 | regulation of neurotransmitter levels (GO:0001505) | 3.17870188 |
| 106 | behavioral defense response (GO:0002209) | 3.16499011 |
| 107 | behavioral fear response (GO:0001662) | 3.16499011 |
| 108 | regulation of ARF protein signal transduction (GO:0032012) | 3.16462483 |
| 109 | synapse assembly (GO:0007416) | 3.14318550 |
| 110 | positive regulation of synaptic transmission (GO:0050806) | 3.12248053 |
| 111 | cardiac muscle hypertrophy (GO:0003300) | 3.11546267 |
| 112 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.11117452 |
| 113 | regulation of glutamate secretion (GO:0014048) | 3.10847560 |
| 114 | dendritic spine organization (GO:0097061) | 3.10840632 |
| 115 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.10225138 |
| 116 | behavioral response to cocaine (GO:0048148) | 3.09993449 |
| 117 | presynaptic membrane organization (GO:0097090) | 3.09530621 |
| 118 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.08019765 |
| 119 | detection of calcium ion (GO:0005513) | 3.07832228 |
| 120 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.07641630 |
| 121 | axonal fasciculation (GO:0007413) | 3.07313924 |
| 122 | membrane hyperpolarization (GO:0060081) | 3.06361004 |
| 123 | mechanosensory behavior (GO:0007638) | 3.05601659 |
| 124 | membrane depolarization during action potential (GO:0086010) | 3.04576362 |
| 125 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.03407984 |
| 126 | regulation of synaptic transmission (GO:0050804) | 3.03061189 |
| 127 | neuronal ion channel clustering (GO:0045161) | 3.02451897 |
| 128 | positive regulation of dendritic spine development (GO:0060999) | 3.01342398 |
| 129 | neurotransmitter uptake (GO:0001504) | 3.01104525 |
| 130 | regulation of female receptivity (GO:0045924) | 2.99932350 |
| 131 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.99614002 |
| 132 | * synaptic transmission (GO:0007268) | 2.99222522 |
| 133 | striatum development (GO:0021756) | 2.99016863 |
| 134 | response to amphetamine (GO:0001975) | 2.98219167 |
| 135 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.98122240 |
| 136 | creatine metabolic process (GO:0006600) | 2.98001733 |
| 137 | sleep (GO:0030431) | 2.97752668 |
| 138 | dendrite morphogenesis (GO:0048813) | 2.97641946 |
| 139 | striated muscle hypertrophy (GO:0014897) | 2.93301744 |
| 140 | actin filament-based movement (GO:0030048) | 2.92419336 |
| 141 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.91891785 |
| 142 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.91412345 |
| 143 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.91412345 |
| 144 | cardiac myofibril assembly (GO:0055003) | 2.90255846 |
| 145 | relaxation of muscle (GO:0090075) | 2.89923235 |
| 146 | positive regulation of fibroblast migration (GO:0010763) | 2.87198174 |
| 147 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.82544064 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.75747444 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.02177373 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.14482455 |
| 4 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.10056429 |
| 5 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.08699426 |
| 6 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.94781938 |
| 7 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.70044804 |
| 8 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.69434079 |
| 9 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.62110591 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.61163975 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.61163975 |
| 12 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.56639560 |
| 13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.54320402 |
| 14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.44339074 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.44163621 |
| 16 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.42926005 |
| 17 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.42839332 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.39879965 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.33618224 |
| 20 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.20713411 |
| 21 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.19564644 |
| 22 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.18188862 |
| 23 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.15474700 |
| 24 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.14629630 |
| 25 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.14148958 |
| 26 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.08651302 |
| 27 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.97286561 |
| 28 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.96086358 |
| 29 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.92783433 |
| 30 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.91093934 |
| 31 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.87755180 |
| 32 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.82762122 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.75463091 |
| 34 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.75236494 |
| 35 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.71057020 |
| 36 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.70838564 |
| 37 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.70263510 |
| 38 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.70192566 |
| 39 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.69702548 |
| 40 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.67784059 |
| 41 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.65055112 |
| 42 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.64741276 |
| 43 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.60666103 |
| 44 | P300_19829295_ChIP-Seq_ESCs_Human | 1.53727384 |
| 45 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.52667639 |
| 46 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.41734731 |
| 47 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.41493569 |
| 48 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.37237616 |
| 49 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.36530998 |
| 50 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.36471317 |
| 51 | AR_25329375_ChIP-Seq_VCAP_Human | 1.36412757 |
| 52 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36225097 |
| 53 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.35582534 |
| 54 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.35582534 |
| 55 | STAT3_23295773_ChIP-Seq_U87_Human | 1.35177631 |
| 56 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.32374791 |
| 57 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.31171935 |
| 58 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.29890619 |
| 59 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.28761921 |
| 60 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.27729242 |
| 61 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.26656232 |
| 62 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.26502508 |
| 63 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24801744 |
| 64 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.24688913 |
| 65 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.24552861 |
| 66 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.23012894 |
| 67 | AR_19668381_ChIP-Seq_PC3_Human | 1.22882439 |
| 68 | KDM2B_26808549_Chip-Seq_K562_Human | 1.22508616 |
| 69 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.22385946 |
| 70 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.21981017 |
| 71 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.21896464 |
| 72 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.20599827 |
| 73 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.20551225 |
| 74 | TCF4_23295773_ChIP-Seq_U87_Human | 1.20534251 |
| 75 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.19383057 |
| 76 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18592507 |
| 77 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.17309568 |
| 78 | * ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.17276008 |
| 79 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16996842 |
| 80 | GATA1_22025678_ChIP-Seq_K562_Human | 1.16165649 |
| 81 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.16119046 |
| 82 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.15981893 |
| 83 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.15823965 |
| 84 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.15586709 |
| 85 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.15302669 |
| 86 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.15217440 |
| 87 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.12795762 |
| 88 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11220684 |
| 89 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.10562380 |
| 90 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.09358351 |
| 91 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.09116950 |
| 92 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.08553185 |
| 93 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.08547831 |
| 94 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.08101766 |
| 95 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.08003072 |
| 96 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.06382425 |
| 97 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.06148435 |
| 98 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.06001682 |
| 99 | * FUS_26573619_Chip-Seq_HEK293_Human | 1.05664350 |
| 100 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05241748 |
| 101 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.05086955 |
| 102 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.04960470 |
| 103 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.02401756 |
| 104 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.02373441 |
| 105 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.01701002 |
| 106 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.01059736 |
| 107 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.99089467 |
| 108 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.98812866 |
| 109 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98538447 |
| 110 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98106807 |
| 111 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.98057517 |
| 112 | TP53_16413492_ChIP-PET_HCT116_Human | 0.97550152 |
| 113 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.97232299 |
| 114 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96905897 |
| 115 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.96387331 |
| 116 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.96259991 |
| 117 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.95580683 |
| 118 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95580683 |
| 119 | * DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.95518311 |
| 120 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.95292536 |
| 121 | * JUN_21703547_ChIP-Seq_K562_Human | 0.95257771 |
| 122 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.94199392 |
| 123 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93461729 |
| 124 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92530817 |
| 125 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.92489085 |
| 126 | RXR_22108803_ChIP-Seq_LS180_Human | 0.91845328 |
| 127 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.91842497 |
| 128 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91476720 |
| 129 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.91138377 |
| 130 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.88451600 |
| 131 | MYC_22102868_ChIP-Seq_BL_Human | 0.86640317 |
| 132 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.85079849 |
| 133 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.83888069 |
| 134 | * KDM2B_26808549_Chip-Seq_REH_Human | 0.81647565 |
| 135 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.80237995 |
| 136 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.78957915 |
| 137 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.78613724 |
| 138 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.77566190 |
| 139 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.77090006 |
| 140 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.76857416 |
| 141 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.76674443 |
| 142 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.76640805 |
| 143 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.76624771 |
| 144 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.76262873 |
| 145 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.75800124 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.04337469 |
| 2 | MP0003880_abnormal_central_pattern | 4.54313347 |
| 3 | MP0002822_catalepsy | 4.42335390 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 4.34420484 |
| 5 | MP0004270_analgesia | 3.83447621 |
| 6 | MP0009745_abnormal_behavioral_response | 3.71581564 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.58683299 |
| 8 | MP0000749_muscle_degeneration | 3.48977456 |
| 9 | MP0002064_seizures | 3.17192812 |
| 10 | MP0001968_abnormal_touch/_nociception | 3.13989960 |
| 11 | MP0009046_muscle_twitch | 3.01939839 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.90654029 |
| 13 | MP0004036_abnormal_muscle_relaxation | 2.71579667 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.68678750 |
| 15 | MP0001486_abnormal_startle_reflex | 2.67208577 |
| 16 | MP0005423_abnormal_somatic_nervous | 2.53892717 |
| 17 | MP0002735_abnormal_chemical_nociception | 2.48714744 |
| 18 | MP0002272_abnormal_nervous_system | 2.48453866 |
| 19 | MP0002736_abnormal_nociception_after | 2.44221740 |
| 20 | MP0000759_abnormal_skeletal_muscle | 2.18552327 |
| 21 | MP0001501_abnormal_sleep_pattern | 2.15926280 |
| 22 | MP0000747_muscle_weakness | 2.14918780 |
| 23 | MP0001440_abnormal_grooming_behavior | 2.05831757 |
| 24 | MP0005646_abnormal_pituitary_gland | 2.02198661 |
| 25 | MP0002733_abnormal_thermal_nociception | 1.99537938 |
| 26 | MP0001970_abnormal_pain_threshold | 1.98945819 |
| 27 | MP0009780_abnormal_chondrocyte_physiolo | 1.95148829 |
| 28 | MP0002106_abnormal_muscle_physiology | 1.92117410 |
| 29 | MP0005386_behavior/neurological_phenoty | 1.90427012 |
| 30 | MP0004924_abnormal_behavior | 1.90427012 |
| 31 | MP0002067_abnormal_sensory_capabilities | 1.90150438 |
| 32 | MP0004084_abnormal_cardiac_muscle | 1.87243986 |
| 33 | MP0008569_lethality_at_weaning | 1.86535965 |
| 34 | MP0004087_abnormal_muscle_fiber | 1.85692901 |
| 35 | MP0004811_abnormal_neuron_physiology | 1.81684106 |
| 36 | MP0002557_abnormal_social/conspecific_i | 1.78637059 |
| 37 | MP0001188_hyperpigmentation | 1.77741113 |
| 38 | MP0002184_abnormal_innervation | 1.73074628 |
| 39 | MP0000778_abnormal_nervous_system | 1.69034446 |
| 40 | MP0003879_abnormal_hair_cell | 1.67113634 |
| 41 | MP0004858_abnormal_nervous_system | 1.63642785 |
| 42 | MP0001529_abnormal_vocalization | 1.62581640 |
| 43 | MP0002269_muscular_atrophy | 1.60107465 |
| 44 | MP0002909_abnormal_adrenal_gland | 1.59678685 |
| 45 | MP0005369_muscle_phenotype | 1.59049775 |
| 46 | MP0003787_abnormal_imprinting | 1.56617284 |
| 47 | MP0001984_abnormal_olfaction | 1.53480333 |
| 48 | MP0004147_increased_porphyrin_level | 1.47391252 |
| 49 | MP0000569_abnormal_digit_pigmentation | 1.46323345 |
| 50 | MP0000955_abnormal_spinal_cord | 1.46001873 |
| 51 | MP0002332_abnormal_exercise_endurance | 1.45993898 |
| 52 | MP0003045_fibrosis | 1.42430316 |
| 53 | MP0003329_amyloid_beta_deposits | 1.38338073 |
| 54 | MP0000372_irregular_coat_pigmentation | 1.37915286 |
| 55 | MP0005451_abnormal_body_composition | 1.36753062 |
| 56 | MP0003633_abnormal_nervous_system | 1.36408175 |
| 57 | MP0002066_abnormal_motor_capabilities/c | 1.35639248 |
| 58 | MP0005645_abnormal_hypothalamus_physiol | 1.29187054 |
| 59 | MP0002882_abnormal_neuron_morphology | 1.28946555 |
| 60 | MP0001905_abnormal_dopamine_level | 1.23185928 |
| 61 | MP0006276_abnormal_autonomic_nervous | 1.22380239 |
| 62 | MP0005330_cardiomyopathy | 1.22011984 |
| 63 | MP0000733_abnormal_muscle_development | 1.21048211 |
| 64 | MP0005623_abnormal_meninges_morphology | 1.20038946 |
| 65 | MP0001502_abnormal_circadian_rhythm | 1.18051763 |
| 66 | MP0002837_dystrophic_cardiac_calcinosis | 1.15230730 |
| 67 | MP0005409_darkened_coat_color | 1.13383626 |
| 68 | MP0002396_abnormal_hematopoietic_system | 1.13226358 |
| 69 | MP0010386_abnormal_urinary_bladder | 1.12210686 |
| 70 | MP0003631_nervous_system_phenotype | 1.11761261 |
| 71 | MP0008872_abnormal_physiological_respon | 1.08132973 |
| 72 | MP0008874_decreased_physiological_sensi | 1.07124372 |
| 73 | MP0001177_atelectasis | 1.04510912 |
| 74 | MP0004142_abnormal_muscle_tone | 1.03448583 |
| 75 | MP0004885_abnormal_endolymph | 1.02913083 |
| 76 | MP0002972_abnormal_cardiac_muscle | 1.00395714 |
| 77 | MP0002152_abnormal_brain_morphology | 1.00037971 |
| 78 | MP0003075_altered_response_to | 0.96374181 |
| 79 | MP0004510_myositis | 0.92713128 |
| 80 | MP0002069_abnormal_eating/drinking_beha | 0.91121442 |
| 81 | MP0006036_abnormal_mitochondrial_physio | 0.90000234 |
| 82 | MP0000751_myopathy | 0.86117692 |
| 83 | MP0001348_abnormal_lacrimal_gland | 0.85812166 |
| 84 | MP0004742_abnormal_vestibular_system | 0.83918842 |
| 85 | MP0000750_abnormal_muscle_regeneration | 0.83912420 |
| 86 | MP0004145_abnormal_muscle_electrophysio | 0.82871160 |
| 87 | MP0004484_altered_response_of | 0.82773567 |
| 88 | MP0002877_abnormal_melanocyte_morpholog | 0.82248068 |
| 89 | MP0002090_abnormal_vision | 0.80442536 |
| 90 | MP0005535_abnormal_body_temperature | 0.78394167 |
| 91 | MP0001963_abnormal_hearing_physiology | 0.77985661 |
| 92 | MP0001346_abnormal_lacrimal_gland | 0.77200648 |
| 93 | MP0004085_abnormal_heartbeat | 0.76346618 |
| 94 | MP0008057_abnormal_DNA_replication | 0.74989901 |
| 95 | MP0005171_absent_coat_pigmentation | 0.71938326 |
| 96 | MP0002638_abnormal_pupillary_reflex | 0.71682657 |
| 97 | MP0002229_neurodegeneration | 0.71680529 |
| 98 | MP0010630_abnormal_cardiac_muscle | 0.71483639 |
| 99 | MP0006138_congestive_heart_failure | 0.71261829 |
| 100 | MP0002876_abnormal_thyroid_physiology | 0.70224961 |
| 101 | MP0003122_maternal_imprinting | 0.69803540 |
| 102 | MP0004134_abnormal_chest_morphology | 0.69549520 |
| 103 | MP0000631_abnormal_neuroendocrine_gland | 0.68624215 |
| 104 | MP0000015_abnormal_ear_pigmentation | 0.68089941 |
| 105 | MP0003950_abnormal_plasma_membrane | 0.66883572 |
| 106 | MP0005394_taste/olfaction_phenotype | 0.65132903 |
| 107 | MP0005499_abnormal_olfactory_system | 0.65132903 |
| 108 | MP0008961_abnormal_basal_metabolism | 0.65030564 |
| 109 | MP0001299_abnormal_eye_distance/ | 0.64365682 |
| 110 | MP0005551_abnormal_eye_electrophysiolog | 0.63829907 |
| 111 | MP0004043_abnormal_pH_regulation | 0.62750495 |
| 112 | MP0003632_abnormal_nervous_system | 0.61955522 |
| 113 | MP0005075_abnormal_melanosome_morpholog | 0.61437967 |
| 114 | MP0002752_abnormal_somatic_nervous | 0.60768918 |
| 115 | MP0005174_abnormal_tail_pigmentation | 0.60432758 |
| 116 | MP0001664_abnormal_digestion | 0.60232680 |
| 117 | MP0005266_abnormal_metabolism | 0.59582440 |
| 118 | MP0000013_abnormal_adipose_tissue | 0.58684676 |
| 119 | MP0000920_abnormal_myelination | 0.58461112 |
| 120 | MP0002108_abnormal_muscle_morphology | 0.57883322 |
| 121 | MP0003690_abnormal_glial_cell | 0.56539683 |
| 122 | MP0003172_abnormal_lysosome_physiology | 0.56415858 |
| 123 | MP0003634_abnormal_glial_cell | 0.55585717 |
| 124 | MP0005167_abnormal_blood-brain_barrier | 0.54525147 |
| 125 | MP0004215_abnormal_myocardial_fiber | 0.54230326 |
| 126 | MP0003646_muscle_fatigue | 0.53070785 |
| 127 | MP0001943_abnormal_respiration | 0.52562268 |
| 128 | MP0000604_amyloidosis | 0.52105898 |
| 129 | MP0004130_abnormal_muscle_cell | 0.51887114 |
| 130 | MP0003283_abnormal_digestive_organ | 0.51581576 |
| 131 | MP0005166_decreased_susceptibility_to | 0.51567932 |
| 132 | MP0004233_abnormal_muscle_weight | 0.51551728 |
| 133 | MP0003137_abnormal_impulse_conducting | 0.48967337 |
| 134 | MP0010769_abnormal_survival | 0.47966541 |
| 135 | MP0003956_abnormal_body_size | 0.47248967 |
| 136 | MP0005620_abnormal_muscle_contractility | 0.47176324 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.78866943 |
| 2 | Myokymia (HP:0002411) | 7.62441381 |
| 3 | Muscle fiber inclusion bodies (HP:0100299) | 7.59900248 |
| 4 | Nemaline bodies (HP:0003798) | 7.47967243 |
| 5 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 7.27322399 |
| 6 | Focal seizures (HP:0007359) | 6.02935967 |
| 7 | Type 1 muscle fiber predominance (HP:0003803) | 5.78369170 |
| 8 | Exercise-induced myalgia (HP:0003738) | 5.67681194 |
| 9 | Febrile seizures (HP:0002373) | 5.46767190 |
| 10 | Epileptic encephalopathy (HP:0200134) | 5.40855048 |
| 11 | Visual hallucinations (HP:0002367) | 5.17736267 |
| 12 | Exercise-induced muscle cramps (HP:0003710) | 4.90243867 |
| 13 | Atonic seizures (HP:0010819) | 4.76080017 |
| 14 | Absence seizures (HP:0002121) | 4.27439566 |
| 15 | Generalized tonic-clonic seizures (HP:0002069) | 4.17339095 |
| 16 | Broad-based gait (HP:0002136) | 4.17062689 |
| 17 | Poor eye contact (HP:0000817) | 4.11699071 |
| 18 | Dialeptic seizures (HP:0011146) | 3.91122352 |
| 19 | Papilledema (HP:0001085) | 3.85302330 |
| 20 | Progressive cerebellar ataxia (HP:0002073) | 3.84809301 |
| 21 | Distal arthrogryposis (HP:0005684) | 3.78869294 |
| 22 | Subaortic stenosis (HP:0001682) | 3.76704049 |
| 23 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.76704049 |
| 24 | Hyporeflexia of lower limbs (HP:0002600) | 3.72800441 |
| 25 | Hyperventilation (HP:0002883) | 3.72571166 |
| 26 | Myopathic facies (HP:0002058) | 3.68370010 |
| 27 | EMG: myopathic abnormalities (HP:0003458) | 3.66837676 |
| 28 | Abnormal social behavior (HP:0012433) | 3.62417919 |
| 29 | Impaired social interactions (HP:0000735) | 3.62417919 |
| 30 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.62082142 |
| 31 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.54700555 |
| 32 | Action tremor (HP:0002345) | 3.53024687 |
| 33 | Gaze-evoked nystagmus (HP:0000640) | 3.50196669 |
| 34 | Ankle clonus (HP:0011448) | 3.50079958 |
| 35 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.41531068 |
| 36 | Sudden death (HP:0001699) | 3.38009640 |
| 37 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.36822172 |
| 38 | Rhabdomyolysis (HP:0003201) | 3.31454164 |
| 39 | Round ear (HP:0100830) | 3.25315604 |
| 40 | Mutism (HP:0002300) | 3.23991933 |
| 41 | Calf muscle hypertrophy (HP:0008981) | 3.20448291 |
| 42 | Depression (HP:0000716) | 3.20390257 |
| 43 | Amblyopia (HP:0000646) | 3.18361822 |
| 44 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.16041852 |
| 45 | Neck muscle weakness (HP:0000467) | 3.05981658 |
| 46 | Myoglobinuria (HP:0002913) | 3.05490201 |
| 47 | Muscle stiffness (HP:0003552) | 3.04440683 |
| 48 | Fetal akinesia sequence (HP:0001989) | 3.02862797 |
| 49 | Dysdiadochokinesis (HP:0002075) | 3.02170864 |
| 50 | Anxiety (HP:0000739) | 2.97111136 |
| 51 | Stereotypic behavior (HP:0000733) | 2.95932008 |
| 52 | Progressive inability to walk (HP:0002505) | 2.94107916 |
| 53 | Supranuclear gaze palsy (HP:0000605) | 2.93100330 |
| 54 | Difficulty running (HP:0009046) | 2.91793603 |
| 55 | Postural instability (HP:0002172) | 2.91780001 |
| 56 | Torticollis (HP:0000473) | 2.89066534 |
| 57 | Muscle fiber splitting (HP:0003555) | 2.87077575 |
| 58 | Inability to walk (HP:0002540) | 2.86237918 |
| 59 | Truncal ataxia (HP:0002078) | 2.85111546 |
| 60 | Myotonia (HP:0002486) | 2.82259318 |
| 61 | Abnormality of the calf musculature (HP:0001430) | 2.82229735 |
| 62 | Ulnar deviation of the wrist (HP:0003049) | 2.76187593 |
| 63 | Dysmetria (HP:0001310) | 2.75751393 |
| 64 | Increased variability in muscle fiber diameter (HP:0003557) | 2.74811486 |
| 65 | Excessive salivation (HP:0003781) | 2.74774512 |
| 66 | Drooling (HP:0002307) | 2.74774512 |
| 67 | Urinary urgency (HP:0000012) | 2.74487456 |
| 68 | Lower limb amyotrophy (HP:0007210) | 2.73371944 |
| 69 | Abnormal eating behavior (HP:0100738) | 2.68800184 |
| 70 | Frequent falls (HP:0002359) | 2.68228140 |
| 71 | Epileptiform EEG discharges (HP:0011182) | 2.64317435 |
| 72 | Focal dystonia (HP:0004373) | 2.64244929 |
| 73 | Absent speech (HP:0001344) | 2.64155179 |
| 74 | Impaired smooth pursuit (HP:0007772) | 2.59141615 |
| 75 | Increased connective tissue (HP:0009025) | 2.53023935 |
| 76 | Bradykinesia (HP:0002067) | 2.51839957 |
| 77 | EEG with generalized epileptiform discharges (HP:0011198) | 2.51641844 |
| 78 | Heart block (HP:0012722) | 2.50435367 |
| 79 | Impaired vibratory sensation (HP:0002495) | 2.49433350 |
| 80 | Annular pancreas (HP:0001734) | 2.48891653 |
| 81 | EMG: neuropathic changes (HP:0003445) | 2.44742079 |
| 82 | Tetraplegia (HP:0002445) | 2.43068750 |
| 83 | Resting tremor (HP:0002322) | 2.42234228 |
| 84 | Spastic gait (HP:0002064) | 2.41757043 |
| 85 | Scanning speech (HP:0002168) | 2.40477453 |
| 86 | Abnormal atrioventricular conduction (HP:0005150) | 2.39988807 |
| 87 | Genetic anticipation (HP:0003743) | 2.39854735 |
| 88 | Inappropriate behavior (HP:0000719) | 2.39529925 |
| 89 | Abnormality of binocular vision (HP:0011514) | 2.36791894 |
| 90 | Diplopia (HP:0000651) | 2.36791894 |
| 91 | Hypsarrhythmia (HP:0002521) | 2.36157016 |
| 92 | Calcaneovalgus deformity (HP:0001848) | 2.35327402 |
| 93 | Craniofacial dystonia (HP:0012179) | 2.33875713 |
| 94 | Cerebral hypomyelination (HP:0006808) | 2.33361450 |
| 95 | Rimmed vacuoles (HP:0003805) | 2.30390751 |
| 96 | Hemiparesis (HP:0001269) | 2.28357647 |
| 97 | Limb dystonia (HP:0002451) | 2.23400116 |
| 98 | Areflexia of lower limbs (HP:0002522) | 2.21218632 |
| 99 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.20605533 |
| 100 | Megalencephaly (HP:0001355) | 2.19589217 |
| 101 | Blue irides (HP:0000635) | 2.18781821 |
| 102 | Slender build (HP:0001533) | 2.16398678 |
| 103 | Dysmetric saccades (HP:0000641) | 2.14617608 |
| 104 | Lower limb muscle weakness (HP:0007340) | 2.13831118 |
| 105 | Generalized myoclonic seizures (HP:0002123) | 2.13271732 |
| 106 | Status epilepticus (HP:0002133) | 2.11458226 |
| 107 | Akinesia (HP:0002304) | 2.11038229 |
| 108 | Incomplete penetrance (HP:0003829) | 2.10974698 |
| 109 | Protruding tongue (HP:0010808) | 2.10078107 |
| 110 | Obstructive sleep apnea (HP:0002870) | 2.09597737 |
| 111 | Pointed chin (HP:0000307) | 2.09061784 |
| 112 | Foot dorsiflexor weakness (HP:0009027) | 2.06718751 |
| 113 | Hemiplegia (HP:0002301) | 2.06491638 |
| 114 | Deformed tarsal bones (HP:0008119) | 2.05971235 |
| 115 | Abnormality of the foot musculature (HP:0001436) | 2.04894469 |
| 116 | Intention tremor (HP:0002080) | 2.04713330 |
| 117 | Abnormal EKG (HP:0003115) | 2.01954495 |
| 118 | Termporal pattern (HP:0011008) | 2.01199434 |
| 119 | Insidious onset (HP:0003587) | 2.01199434 |
| 120 | Mild short stature (HP:0003502) | 2.00807601 |
| 121 | Scapular winging (HP:0003691) | 2.00489293 |
| 122 | Generalized hypopigmentation of hair (HP:0011358) | 1.99460178 |
| 123 | Absent phalangeal crease (HP:0006109) | 1.97486134 |
| 124 | Metaphyseal dysplasia (HP:0100255) | 1.96590096 |
| 125 | Abnormality of salivation (HP:0100755) | 1.95853496 |
| 126 | Abnormality of the lower motor neuron (HP:0002366) | 1.94801189 |
| 127 | Distal lower limb muscle weakness (HP:0009053) | 1.92768255 |
| 128 | Atrioventricular block (HP:0001678) | 1.91084972 |
| 129 | Polyphagia (HP:0002591) | 1.91006295 |
| 130 | Ventricular fibrillation (HP:0001663) | 1.89216048 |
| 131 | Ankyloglossia (HP:0010296) | 1.88454699 |
| 132 | Asymmetric septal hypertrophy (HP:0001670) | 1.85697720 |
| 133 | Deeply set eye (HP:0000490) | 1.83571725 |
| 134 | Clonus (HP:0002169) | 1.83524203 |
| 135 | Abnormality of the corticospinal tract (HP:0002492) | 1.83302630 |
| 136 | Cerebral inclusion bodies (HP:0100314) | 1.81081592 |
| 137 | Lower limb asymmetry (HP:0100559) | 1.80891574 |
| 138 | Intellectual disability, profound (HP:0002187) | 1.79944724 |
| 139 | Aqueductal stenosis (HP:0002410) | 1.78750500 |
| 140 | Amyotrophic lateral sclerosis (HP:0007354) | 1.78750342 |
| 141 | Prolonged QT interval (HP:0001657) | 1.76392067 |
| 142 | Generalized muscle weakness (HP:0003324) | 1.75339318 |
| 143 | Bundle branch block (HP:0011710) | 1.75274968 |
| 144 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.74968451 |
| 145 | Ocular albinism (HP:0001107) | 1.74677967 |
| 146 | Gait ataxia (HP:0002066) | 1.74607531 |
| 147 | Malignant hyperthermia (HP:0002047) | 1.74428496 |
| 148 | Distal lower limb amyotrophy (HP:0008944) | 1.71630566 |
| 149 | Progressive muscle weakness (HP:0003323) | 1.71202554 |
| 150 | Hyperkalemia (HP:0002153) | 1.70615808 |
| 151 | CNS hypomyelination (HP:0003429) | 1.69497092 |
| 152 | Abnormal finger flexion creases (HP:0006143) | 1.68889770 |
| 153 | Delusions (HP:0000746) | 1.68746266 |
| 154 | Spinal canal stenosis (HP:0003416) | 1.67933232 |
| 155 | Fair hair (HP:0002286) | 1.67827856 |
| 156 | Palpebral edema (HP:0100540) | 1.67697171 |
| 157 | Abnormality of the periventricular white matter (HP:0002518) | 1.67215457 |
| 158 | Gait imbalance (HP:0002141) | 1.65120956 |
| 159 | Rigidity (HP:0002063) | 1.65119172 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 6.02872968 |
| 2 | EPHA4 | 5.32359398 |
| 3 | NTRK3 | 4.41946964 |
| 4 | MAP3K9 | 3.55199487 |
| 5 | MARK1 | 3.43388142 |
| 6 | DAPK2 | 2.98151425 |
| 7 | MAP3K4 | 2.77411589 |
| 8 | MAP2K7 | 2.74757850 |
| 9 | MINK1 | 2.65191450 |
| 10 | CASK | 2.57669619 |
| 11 | TTN | 2.43780152 |
| 12 | RIPK4 | 2.41490572 |
| 13 | NTRK2 | 2.00622469 |
| 14 | CAMKK1 | 1.97065608 |
| 15 | PRKD3 | 1.96888214 |
| 16 | MAP3K12 | 1.95411904 |
| 17 | PAK6 | 1.90114426 |
| 18 | DAPK1 | 1.89329673 |
| 19 | KSR2 | 1.86677120 |
| 20 | NTRK1 | 1.83632920 |
| 21 | PRPF4B | 1.82217733 |
| 22 | MAP2K4 | 1.67459647 |
| 23 | KSR1 | 1.62110657 |
| 24 | TNIK | 1.60153861 |
| 25 | SIK2 | 1.59304062 |
| 26 | PLK2 | 1.57566085 |
| 27 | CDK5 | 1.53399698 |
| 28 | MAPK13 | 1.51196593 |
| 29 | FES | 1.43011937 |
| 30 | MAP3K13 | 1.29013769 |
| 31 | PIK3CG | 1.28295151 |
| 32 | PRKCG | 1.23719691 |
| 33 | CAMKK2 | 1.15299450 |
| 34 | GRK5 | 1.12024520 |
| 35 | ARAF | 1.09173880 |
| 36 | BMPR2 | 1.07423829 |
| 37 | MAP2K3 | 1.04482506 |
| 38 | MOS | 1.03807167 |
| 39 | EEF2K | 1.01819531 |
| 40 | CDK19 | 1.01423081 |
| 41 | CAMK1 | 0.99521524 |
| 42 | TAOK1 | 0.98450803 |
| 43 | STK38 | 0.98236427 |
| 44 | PHKG1 | 0.96928086 |
| 45 | PHKG2 | 0.96928086 |
| 46 | MAP3K2 | 0.96807704 |
| 47 | SGK2 | 0.95255383 |
| 48 | TYRO3 | 0.93255945 |
| 49 | PRKCH | 0.92153773 |
| 50 | STK11 | 0.90514568 |
| 51 | RAF1 | 0.89339084 |
| 52 | CAMK2A | 0.88033723 |
| 53 | CCNB1 | 0.87319035 |
| 54 | SGK223 | 0.83092464 |
| 55 | SGK494 | 0.83092464 |
| 56 | CAMK2G | 0.80349197 |
| 57 | TNK2 | 0.79745457 |
| 58 | SGK1 | 0.79455834 |
| 59 | PDK1 | 0.78478194 |
| 60 | BRAF | 0.78393052 |
| 61 | SGK3 | 0.78375799 |
| 62 | NEK9 | 0.75209922 |
| 63 | CDK18 | 0.75081856 |
| 64 | LATS2 | 0.73290996 |
| 65 | TRPM7 | 0.73145169 |
| 66 | CDK15 | 0.71324431 |
| 67 | PINK1 | 0.70666192 |
| 68 | MAPK7 | 0.70014678 |
| 69 | RET | 0.69524892 |
| 70 | NEK6 | 0.68906022 |
| 71 | CDK14 | 0.68737374 |
| 72 | UHMK1 | 0.68705830 |
| 73 | MARK2 | 0.67623170 |
| 74 | ALK | 0.65724697 |
| 75 | PNCK | 0.65231959 |
| 76 | SIK3 | 0.64403164 |
| 77 | MAPK11 | 0.63542420 |
| 78 | AKT3 | 0.62156427 |
| 79 | PDPK1 | 0.62155255 |
| 80 | PTK2B | 0.62136484 |
| 81 | ICK | 0.60999480 |
| 82 | CDK11A | 0.60578271 |
| 83 | PIK3CA | 0.60537995 |
| 84 | PRKCE | 0.58193659 |
| 85 | DYRK1A | 0.57390348 |
| 86 | FLT3 | 0.57064243 |
| 87 | CAMK2B | 0.53316270 |
| 88 | LIMK1 | 0.53296846 |
| 89 | MAPK12 | 0.52170619 |
| 90 | CSNK1G2 | 0.51916744 |
| 91 | MAP3K11 | 0.51872575 |
| 92 | WNK1 | 0.51347508 |
| 93 | NEK1 | 0.50773533 |
| 94 | PRKCZ | 0.50663121 |
| 95 | MAP3K1 | 0.50138563 |
| 96 | MAPK4 | 0.49754709 |
| 97 | MAP3K7 | 0.48073838 |
| 98 | AKT2 | 0.47449419 |
| 99 | RIPK1 | 0.46244269 |
| 100 | FYN | 0.45526153 |
| 101 | RPS6KA3 | 0.45056049 |
| 102 | CAMK2D | 0.45039421 |
| 103 | MAP2K1 | 0.43537988 |
| 104 | CAMK4 | 0.43264268 |
| 105 | KIT | 0.43137922 |
| 106 | TRIB3 | 0.42934290 |
| 107 | SCYL2 | 0.40272580 |
| 108 | ERBB3 | 0.39900783 |
| 109 | DMPK | 0.39169764 |
| 110 | PAK3 | 0.38604513 |
| 111 | DAPK3 | 0.37188845 |
| 112 | MAPKAPK5 | 0.36250422 |
| 113 | LMTK2 | 0.35513862 |
| 114 | LATS1 | 0.35500143 |
| 115 | MAP2K6 | 0.34815398 |
| 116 | RPS6KA2 | 0.34311734 |
| 117 | MAP3K6 | 0.33933602 |
| 118 | PRKCB | 0.33793987 |
| 119 | MAPK10 | 0.33479586 |
| 120 | SYK | 0.33079391 |
| 121 | NME1 | 0.32935850 |
| 122 | BRSK1 | 0.32843953 |
| 123 | OXSR1 | 0.31953292 |
| 124 | MUSK | 0.31383118 |
| 125 | CDK12 | 0.30018946 |
| 126 | FGR | 0.29330407 |
| 127 | PAK2 | 0.29009032 |
| 128 | PRKG1 | 0.28775364 |
| 129 | PKN1 | 0.28137543 |
| 130 | RPS6KB1 | 0.25944354 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.42246227 |
| 2 | Olfactory transduction_Homo sapiens_hsa04740 | 3.15121276 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.15051610 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.75860951 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.66537538 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 2.66178856 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.60022813 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.57181425 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.50249301 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.49855123 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.19016280 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.16814210 |
| 13 | * Cholinergic synapse_Homo sapiens_hsa04725 | 2.02858105 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 1.93951404 |
| 15 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.91858748 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.89279332 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.86589713 |
| 18 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.84021653 |
| 19 | Renin secretion_Homo sapiens_hsa04924 | 1.83951624 |
| 20 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.79916808 |
| 21 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.71681094 |
| 22 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.67571127 |
| 23 | Cocaine addiction_Homo sapiens_hsa05030 | 1.65971271 |
| 24 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.65812693 |
| 25 | Taste transduction_Homo sapiens_hsa04742 | 1.59076998 |
| 26 | Long-term depression_Homo sapiens_hsa04730 | 1.57819938 |
| 27 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.45965499 |
| 28 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.44668158 |
| 29 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.33184081 |
| 30 | Gap junction_Homo sapiens_hsa04540 | 1.33166710 |
| 31 | Glioma_Homo sapiens_hsa05214 | 1.29762993 |
| 32 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.28629332 |
| 33 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.27848137 |
| 34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.24671524 |
| 35 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.22392908 |
| 36 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.14785196 |
| 37 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.13184212 |
| 38 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.12582939 |
| 39 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.11570601 |
| 40 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.10564200 |
| 41 | Axon guidance_Homo sapiens_hsa04360 | 1.10252506 |
| 42 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.09682870 |
| 43 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.09423045 |
| 44 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.01834509 |
| 45 | Melanogenesis_Homo sapiens_hsa04916 | 1.00174253 |
| 46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.99867478 |
| 47 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.91189433 |
| 48 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.89564831 |
| 49 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.88601896 |
| 50 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.81285515 |
| 51 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.81239342 |
| 52 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.79798812 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.79710613 |
| 54 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.78549349 |
| 55 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.78352020 |
| 56 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.77680253 |
| 57 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.76880510 |
| 58 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.74294182 |
| 59 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.73221186 |
| 60 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.72965695 |
| 61 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.72334920 |
| 62 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.72196480 |
| 63 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.71672754 |
| 64 | Phototransduction_Homo sapiens_hsa04744 | 0.71247399 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.70390779 |
| 66 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68636341 |
| 67 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.65212548 |
| 68 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.65008250 |
| 69 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.64671537 |
| 70 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.63999410 |
| 71 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.63505944 |
| 72 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.63216525 |
| 73 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62461919 |
| 74 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.62224012 |
| 75 | Focal adhesion_Homo sapiens_hsa04510 | 0.61400585 |
| 76 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.61039884 |
| 77 | Endometrial cancer_Homo sapiens_hsa05213 | 0.59617070 |
| 78 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.57040826 |
| 79 | Alcoholism_Homo sapiens_hsa05034 | 0.56103986 |
| 80 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.55987402 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.55318839 |
| 82 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.55038720 |
| 83 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.53303807 |
| 84 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52985653 |
| 85 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.52072269 |
| 86 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.51791841 |
| 87 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51784463 |
| 88 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.49534132 |
| 89 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.48680869 |
| 90 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.46042512 |
| 91 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.45967435 |
| 92 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.45236638 |
| 93 | Endocytosis_Homo sapiens_hsa04144 | 0.44608853 |
| 94 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44546724 |
| 95 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.44110864 |
| 96 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.43448457 |
| 97 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.42720954 |
| 98 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.42397874 |
| 99 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.41556874 |
| 100 | Circadian rhythm_Homo sapiens_hsa04710 | 0.41509068 |
| 101 | Platelet activation_Homo sapiens_hsa04611 | 0.41070824 |
| 102 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.40979896 |
| 103 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.40493460 |
| 104 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.40024285 |
| 105 | Carbon metabolism_Homo sapiens_hsa01200 | 0.39822179 |
| 106 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.39224748 |
| 107 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38791386 |
| 108 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.38298932 |
| 109 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.37124220 |
| 110 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.36650860 |
| 111 | Colorectal cancer_Homo sapiens_hsa05210 | 0.36566476 |
| 112 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.36089197 |
| 113 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.35325426 |
| 114 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.35189078 |
| 115 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.35173457 |
| 116 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34129466 |
| 117 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33830357 |
| 118 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.33687293 |
| 119 | Insulin resistance_Homo sapiens_hsa04931 | 0.32646237 |
| 120 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.30051575 |
| 121 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.28715841 |
| 122 | Melanoma_Homo sapiens_hsa05218 | 0.27592261 |

